ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Novartis AG (NVS) Plagued by Plant Problems in Austria, Too


5/4/2012 7:30:31 AM

Over the past few months, Novartis has struggled with a string of problems at several manufacturing plants. Notably, a facility in Nebraska suffered embarrassing gaffes involving over-the-counter meds and animal health drugs (see this and this). And the FDA sent a warning letter last November for “significant violations” at two other US plants – Broomfield, Colorado and Wilson, North Carolina. A Sandoz plant in Quebec, Canada, meanwhile, has since halted some production.However, the drugmaker is having an equally rough time in Europe, where shortages are reported in several countries, including Austria, Belgium, Bulgaria, Czech Republic, Germany, Spain, France, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Romania, Slovenia and Slovakia, according to Polish media.

Read at Pharmalot
 
 Read Article at  Related Companies  News Categories
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES